OmniAb, Inc. (OABI)
NASDAQ: OABI · IEX Real-Time Price · USD
3.670
-0.070 (-1.87%)
At close: Jul 2, 2024, 4:00 PM
3.600
-0.070 (-1.91%)
After-hours: Jul 2, 2024, 7:27 PM EDT
OmniAb Market Cap
OmniAb has a market cap or net worth of $429.85 million as of July 2, 2024. Its market cap has decreased by -19.86% in one year.
Market Cap
429.85M
Enterprise Value
385.22M
1-Year Change
-19.86%
Ranking
Category
Stock Price
$3.67
Market Cap Chart
Since August 10, 2021, OmniAb's market cap has increased from $250.00M to $429.85M, an increase of 71.94%. That is a compound annual growth rate of 20.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2024 | 431.60M | -39.82% |
| Dec 29, 2023 | 717.20M | 79.39% |
| Dec 30, 2022 | 399.80M | 39.06% |
| Dec 31, 2021 | 287.50M | 15.00% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EyePoint Pharmaceuticals | 453.13M |
| Contineum Therapeutics | 452.99M |
| Enhabit | 447.39M |
| LENZ Therapeutics | 441.49M |
| Terns Pharmaceuticals | 440.45M |
| Alector | 437.59M |
| Acelyrin | 436.71M |
| Voyager Therapeutics | 430.25M |